Related Experiment Videos
hBD-1: a novel beta-defensin from human plasma
K W Bensch1, M Raida, H J Mägert
1Niedersächsisches Institut für Peptid-Forschung, Hannover, Germany.
FEBS Letters
|July 17, 1995
Summary
Researchers isolated and characterized human beta-defensin-1 (hBD-1), a novel peptide found in human blood filtrate. This basic peptide has sequence homology to other beta-defensins and is present in plasma.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Beta-defensins are a class of antimicrobial peptides with roles in innate immunity.
- Previous research has identified beta-defensins in various epithelial cells and immune cells.
Purpose of the Study:
- To isolate and characterize a novel peptide from human blood filtrate.
- To determine the sequence, structure, and characteristics of this new peptide.
- To investigate its relationship to known beta-defensins.
Main Methods:
- Peptide isolation from human blood filtrate.
- Amino acid sequencing and mass spectrometry for characterization.
- cDNA cloning to confirm the peptide sequence.
- Sequence homology analysis with known beta-defensins.
Main Results:
- Isolation of a novel peptide, human beta-defensin-1 (hBD-1).
- hBD-1 is a 36-amino acid basic peptide with six cysteines forming disulfide bonds.
- Molecular mass of hBD-1 is 3928.6 Da.
- hBD-1 shows significant sequence homology to other beta-defensins.
- hBD-1 is found in human plasma at nanomolar concentrations.
Conclusions:
- The study successfully isolated and characterized hBD-1, a novel human beta-defensin.
- hBD-1 possesses structural features characteristic of the beta-defensin family.
- The presence of hBD-1 in plasma suggests a potential role in systemic immunity.